openPR Logo
Press release

Retinal Biosimilars Market Shares, Strategies and Forecast Worldwide, 2018 to 2026

01-10-2019 09:47 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Retinal Biosimilars Market Shares, Strategies and Forecast

The retinal biosimilars market has witnessed a remarkable boost with the approval of several retinal biosimilars in 2017. Amgen’s Amgevita in March, f Biogen/Samsung Bioepis’s Imraldi in August, and Boehringer Ingelheim Internationl’s Cyltezo in November were approved in their respective regions. The slow adoption of retinal biosimilars is anticipated due to the initial reluctance of physicians to prescribe retinal biosimilars for individuals who have been using branded products over a long period of time. It is anticipated that retinal biosimilars, over the forecast period, could exploit their commercial potential due to the patent expiration of existing therapies such as Lucentis, Eyela, and others.

Retinal Biosimilars Market: Drivers and Restraints

The growing prevalence and recurrence of retinal diseases is expected to be the major factor driving the growth of the retinal biosimilars market over the coming years. Various initiatives conducted by different organizations across the globe spread awareness related to the treatment and diagnosis of ophthalmic diseases. The International Centre for Eye Health (ICEH) focuses on spreading awareness regarding eye health anomalies and treatment.

The World Glaucoma Congress, organized by the World Glaucoma Association, is conducted every year in order to spread awareness and discuss about the various glaucoma treatments and advancements regarding eye related disorders. Seminars organized by MDA (Macular Degeneration Association, Inc) across various regions promote treatment penetration for age-related macular degeneration (AMD). These initiatives are expected to fuel the growth and increase the adoption of retinal biosimilars. The launch and addition of new retinal biosimilars is another factor contributing to the growth of the global retinal biosimilars market.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2418 

Retinal Biosimilars Market: Segmentation

Tentatively, the global retinal biosimilars market can be segmented on the basis of indication, distribution channel, and geography.

Based on indication, the global biosimilars market is segmented as:

Macular Degeneration
Diabetic Eye Disease
Retinal Detachment
Retinoblastoma
Macular Pucker
Others
Based on distribution channel, the global retinal biosimilars market is segmented as:

Hospital Pharmacies
Drug Stores
Retail Pharmacies
e-Commerce
Retinal Biosimilars Market: Overview

Although the retinal biosimilars market is in its infancy stage, it is expected to witness robust growth over the coming years, globally. There is high competition in the retinal biosimilars market amongst local and regional players. Among the indication segments, the retinoblastoma and macular degeneration segments are expected to lead in the global retinal biosimilars market. The hospital pharmacies segment by distribution channel is expected to contribute a high market revenue share in the retinal biosimilars market, as it is the most accessible channel with a majority of patients and treatment seekers. The pharmaceutical industry is witnessing various technological advancements, and these advancements offer robust features and facilities to patients, which is further expected to drive the growth of the retinal biosimilars market.

Get Access To TOC Covering 200+ Topics: https://www.factmr.com/connectus/sample?flag=T&rep_id=2418 

Retinal Biosimilars Market: Regional Outlook

On the basis of geography, the global retinal biosimilars market is segmented into six key regions, viz. North America, Latin America, Europe, Asia Pacific excluding China, China, and the Middle East & Africa. North America is expected to hold maximum market share in the global retinal biosimilars market, majorly due to the country’s strong economy, increasing patient awareness, technological innovation, and high investments in research and development. Europe is expected to hold the second-highest market share in the global retinal biosimilars market, owing to the increasing prevalence of eye diseases. The Asia Pacific retinal biosimilars market is anticipated to hold a significant share in the global retinal biosimilars market, due to the developing economy and the presence of key manufacturers. The Latin American retinal biosimilars market is expected to show potential growth opportunities in the near future, due to extensive developments in the healthcare infrastructure. However, the Middle East & Africa is expected to register the least market share in the global retinal biosimilars market.

Retinal Biosimilars Market: Key Players

The global market for retinal biosimilars is highly competitive. Examples of some of the key players operating in the global retinal biosimilars market are Reliance Life Sciences, Hetero Drugs Limited, PFENEX INC, Intas Pharmaceuticals, Santo Holding, Sandoz Inc, Genentech USA Inc, Regeneron, Shire Plc, Bayer AG, and others.

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/report/2418/retinal-biosimilars-market 

About US

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Biosimilars Market Shares, Strategies and Forecast Worldwide, 2018 to 2026 here

News-ID: 1486087 • Views: 157

More Releases from Fact.MR

11-09-2020 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel

All 5 Releases


More Releases for Retinal

Retinal Biosimilars Market Opportunity by 2026
The retinal biosimilars market has witnessed a remarkable boost with the approval of several retinal biosimilars in 2017. Amgen’s Amgevita in March, f Biogen/Samsung Bioepis’s Imraldi in August, and Boehringer Ingelheim Internationl’s Cyltezo in November were approved in their respective regions. The slow adoption of retinal biosimilars is anticipated due to the initial reluctance of physicians to prescribe retinal biosimilars for individuals who have been using branded products over a
Global Retinal Implants Market 2018 - Centrasight, Retinal Implant, Boston Retin …
Eminent Market Reports, recently published a detailed market research study focused on the “Retinal Implants Market” across the global, regional and country level. The report provides 360° analysis of “Retinal Implants Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Retinal Implants on
Retinal Disorders – Therapy Market Snapshot
Boston, MA ReportsWorldwide has announced the addition of a new report title Retinal Disorders – Therapy Market Snapshot to its growing collection of premium market research reports. A range of disorders, some of which share similar underlying pathologies, can affect the retina and lead to progressively worsening vision and eventual blindness. The retina is the layer of light-sensitive tissue at the back of the eye that converts light into impulses to the
Retinal Surgery Devices Market: Regional & Competitive Analysis
As per the statistical analysis of TMR, a revenue valuation of around US$2.01 bn has been anticipated to be obtained by the global retinal surgery devices market in 2020. Despite holding a king’s share for retinal surgery devices in the recent past, vitrectomy packs could showcase a faster growth during the course of the forecast period. According to regional analysis, North America could take the driver’s seat while operating at
Retinal Surgery Devices Market Outlook
Retinal surgery devices are undergoing rapid technological advancement to establish an effective treatment platform for various retinal diseases. For instance, minimally invasive surgical instruments for the treatment of retinal diseases offer advantages such as lesser pain, minor scarring, quick recovery and reduced health care costs. Applications of retinal surgery devices across various ophthalmic conditions such as diabetic retinopathy, retinal detachment, epiretinal membrane and macular hole are driving the growth of
Retinal Implants Sales Market Report 2017: Second Sight, Boston Retinal Implant …
In this report, the global Retinal Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request for sample of Retinal Implants Market research report @ https://www.qyresearchgroups.com/request-sample/364879 Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Retinal